Back
Speaker illustration

undefined undefined undefined

Presentations

The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data

Event: ESC Congress 2024

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular disease in the elderly

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources